imgimg
imgimg
img
img
imgimg
首页
公共政策研究院
關於公共政策研究院
研究領域
img
精選內容
最新消息
研究刊物資料庫
img
活動回顧
img
中國文化研究院
香港地方志中心
活動資​​訊
媒體中心
關於我們
關於團結香港基金
img
惠澤機構/人士
img
管治架構
團結香港基金
img
中國文化研究院
img
香港地方志中心
img
顧問成員
img
管理層
法律及審計事務
年報
加入我們
聯絡我們
立即捐款
imgimgimgimgimgimgimg
Banner
最新动态

OHKF Deputy Research Director Victor Kwok Invited as Moderator for Roundtable Discussion on Advancing Innovative Medicines

2026年5月21日 (周四)

Victor Kwok, Deputy Research Director of Our Hong Kong Foundation (OHKF), was invited to attend and moderate the “Roundtable Discussion on Advancing Innovative Medicines,” co-organised by the Cancer Patient Alliance and 长期病患者关注医疗改革联席 on 2 May.

Guests of the roundtable discussion included Assistant Director of Health (Preparatory Office for Centre for Medical Products Regulation) of Department of Health Chan Sze-Tao, Lot, Director (Cluster Services) of the Hospital Authority Dr Wong Yiu-chung; Member of the Legislative Council Dr Hon Chan Han-pan, BBS, JP; academic experts; and representatives from pharmaceutical companies.

The meeting focused on Hong Kong's performance in developing healthcare innovation and recommendations for further improvements to the current mechanisms for approving and registering innovative drugs, as well as strengthening support for local clinical research and drug development.


最后更新于 2026年7月15日 (周三)

Victor Kwok, Deputy Research Director of Our Hong Kong Foundation (OHKF), was invited to attend and moderate the “Roundtable Discussion on Advancing Innovative Medicines,” co-organised by the Cancer Patient Alliance and 长期病患者关注医疗改革联席 on 2 May.

Guests of the roundtable discussion included Assistant Director of Health (Preparatory Office for Centre for Medical Products Regulation) of Department of Health Chan Sze-Tao, Lot, Director (Cluster Services) of the Hospital Authority Dr Wong Yiu-chung; Member of the Legislative Council Dr Hon Chan Han-pan, BBS, JP; academic experts; and representatives from pharmaceutical companies.

The meeting focused on Hong Kong's performance in developing healthcare innovation and recommendations for further improvements to the current mechanisms for approving and registering innovative drugs, as well as strengthening support for local clinical research and drug development.

最后更新于 2026年7月15日 (周三)
支持我们
立即捐款
联络我们
img
香港中环干诺道中88号南丰大厦19楼
img
+852 2603 3001
关注我们
imgimgimgimg
imgimgimg
ESG Care Organization
© 团结香港基金有限公司版权所有
支持我们
立即捐款
联络我们
香港中环干诺道中88号南丰大厦19楼
关注我们
imgimgimgimg
imgimgimg
ESG

© 团结香港基金有限公司版权所有